JOINT FILING AGREEMENT
Exhibit 99.2
In accordance with Rule 13d-1 (k)(l)(iii) under the Securities Exchange Act of 1934, as amended, the person named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value per share, of Cypress Bioscience, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: December 23, 2010
|
ROYALTY PHARMA US PARTNERS 2008, LP
By: Pharmaceutical Investors, L.P.
By: Pharma Management, LLC
ROYALTY PHARMA US PARTNERS, LP
By: Pharmaceutical Investors, L.P.
By: Pharma Management, LLC
ROYALTY PHARMA CAYMAN PARTNERS, LP
By: Pharmaceutical Investors, L.P.
By: Pharma Management, LLC
XXXXX XXXXXXXXX
|
ROYALTY PHARMA CAYMAN PARTNERS 2008, L.P.
By: Pharmaceutical Investors, L.P.
By: Pharma Management, LLC
RP INVESTMENT CORP.
PHARMACEUTICAL INVESTORS, LP
By: Pharma Management, LLC
PHARMA MANAGEMENT, LLC
|
|
By:
|
/s/ Xxxxx Xxxxxxxxx
|
|
Xxxxx Xxxxxxxxx
|
|
|
Authorized Signatory
|
